Apatinib-d8 free base
Cat.No:ILA1831 Solarbio
CAS:2468771-43-7
Purity:≥90%
Qty:
Size:
{{cart_num}}
My CartCAS:2468771-43-7
Purity:≥90%
Qty:
Size:
CAS | 2468771-43-7 |
Name | Apatinib-d8 free base |
Purity | ≥90% |
Target Point | VEGFR2 |
Passage | Angiogenesis; Protein Tyrosine Kinase/RTK |
Background | Apatinib-d8 free base is a deuterium substitute of Apatinib free base. Apatinib free base is an orally bioavailable tyrosine kinase inhibitor that selectively targets VEGFR-2. Apatinib free base effectively inhibits Ret, c-Kit and c-Src activities, as well as cell phosphorylation of VEGFR-2, c-kit and PDGFRβ. |
Unit | Bottle |
Specification | 1mg |
Remark:These protocols are for reference only. Solarbio does not independently validate these methods.
Note:
1. The products are all for scientific research use only. Do not use it for medical, clinical diagnosis or treatment, food and cosmetics, etc. Do not store them in ordinary residential areas.
2. For your safety and health, please wear laboratory clothes, disposable gloves and masks.
3. The experimental results may be affected by many factors, after-sale service is limited to the product itself and does not involve other compensation.
Sorry, there is no experimental images.
Sorry, there is no more information.
Sorry, there is no more information.